WallStreetZenWallStreetZen

NASDAQ: HCWB
Hcw Biologics Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their HCWB stock forecasts and price targets.

Forecast return on equity

Is HCWB forecast to generate an efficient return?

Insufficient data to display

Forecast return on assets

Is HCWB forecast to generate an efficient return on assets?

Company
-24.26%
Industry
92.7%
HCWB is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

HCWB earnings per share forecast

What is HCWB's earnings per share in the next 3 years based on estimates from 3 analysts?

Avg 1 year Forecast
-$4.69
Avg 2 year Forecast
-$5.11
Avg 3 year Forecast
-$2.77

HCWB revenue forecast

What is HCWB's revenue in the next 3 years based on estimates from 3 analysts?

Avg 1 year Forecast
$7.2M+8,373.43%
Avg 2 year Forecast
$0.0-100%
Avg 3 year Forecast
$0.0-100%

HCWB vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
HCWB$2.06N/AN/A
XBIO$2.42N/AN/A
ENSC$1.59N/AN/A
REVB$0.95N/AN/A
CELZ$2.21N/AN/A
View Top Biotech Stocks

Hcw Biologics Stock Forecast FAQ

What is HCWB's earnings growth forecast for 2025-2027?

(NASDAQ: HCWB) Hcw Biologics's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 45.66%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 42.83%.

Hcw Biologics's earnings in 2025 is -$22,206,013.On average, 3 Wall Street analysts forecast HCWB's earnings for 2025 to be -$12,675,940, with the lowest HCWB earnings forecast at -$12,178,844, and the highest HCWB earnings forecast at -$13,048,762. On average, 3 Wall Street analysts forecast HCWB's earnings for 2026 to be -$13,805,752, with the lowest HCWB earnings forecast at -$13,264,350, and the highest HCWB earnings forecast at -$14,211,804.

In 2027, HCWB is forecast to generate -$7,495,338 in earnings, with the lowest earnings forecast at -$7,201,404 and the highest earnings forecast at -$7,715,790.

If you're new to stock investing, here's how to buy Hcw Biologics stock.

What is HCWB's revenue growth forecast for 2025-2027?

(NASDAQ: HCWB) Hcw Biologics's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 103.42%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 25.64%.

Hcw Biologics's revenue in 2025 is $84,405.On average, 3 Wall Street analysts forecast HCWB's revenue for 2025 to be $19,321,893, with the lowest HCWB revenue forecast at $18,565,443, and the highest HCWB revenue forecast at $19,891,932. On average, 3 Wall Street analysts forecast HCWB's revenue for 2026 to be $0, with the lowest HCWB revenue forecast at $0, and the highest HCWB revenue forecast at $0.

In 2027, HCWB is forecast to generate $0 in revenue, with the lowest revenue forecast at $0 and the highest revenue forecast at $0.

What is HCWB's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: HCWB) forecast ROA is -24.26%, which is lower than the forecast US Biotechnology industry average of 92.7%.

What is HCWB's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: HCWB) Hcw Biologics's current Earnings Per Share (EPS) is -$13.21. On average, analysts forecast that HCWB's EPS will be -$4.69 for 2025, with the lowest EPS forecast at -$4.51, and the highest EPS forecast at -$4.83. On average, analysts forecast that HCWB's EPS will be -$5.11 for 2026, with the lowest EPS forecast at -$4.91, and the highest EPS forecast at -$5.26. In 2027, HCWB's EPS is forecast to hit -$2.77 (min: -$2.67, max: -$2.86).

What is HCWB's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: HCWB) forecast ROE is N/A, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.